Lactadherin treatment significantly reduces systemic inflammatory response, decreases immune cell infiltration into the ischemic brain, decreases pro-inflammatory cytokine expression in the IBZ, and increases anti-inflammatory responses in stroke and BDMP treated stroke mice. This evidence concerns the gene MFGE8 and stroke disorder.